Search research articles
Contact Us
Filters
Showing results (11-20 of 171) with videos related to
Page
of 18
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1992
Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects
H A Kleinveld, P N Demacker, A F Stalenhoef
Clinical Chemistry
|
August 1, 1982
Enzymic and chemical-extraction determinations of free fatty acids in serum compared
P N Demacker, A G Hijmans, A P Jansen
British Medical Journal (Clinical Research Ed.)
|
September 20, 1986
Pancreatitis induced by oestrogen in a patient with type I hyperlipoproteinaemia
P M Stuyt, P N Demacker, A F Stalenhoef
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1986
A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia
P M Stuyt, P N Demacker, A van't Laar
Clinical Chemistry
|
June 1, 1984
Suitability of various control sera for use in testing the accuracy of cholesterol determination with enzymic kits
P N Demacker, G J Boerma, A P Jansen
Journal of Internal Medicine
|
December 1, 1991
N-acetylcysteine and serum concentrations of lipoprotein(a)
A A Kroon, P N Demacker, A F Stalenhoef
American Journal of Epidemiology
|
July 1, 1990
Effect of decaffeinated versus regular coffee on serum lipoproteins. A 12-week double-blind trial
M van Dusseldorp, M B Katan, P N Demacker
The Biochemical Journal
|
December 15, 1990
Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol
P N Demacker, M J Mol, A F Stalenhoef
Lancet (London, England)
|
March 20, 1993
Cyclosporin and serum lipids in renal transplant recipients
L B Hilbrands, P N Demacker, A J Hoitsma
Atherosclerosis
|
November 1, 1981
Long-term treatment of type III hyperlipoproteinemia with clofibrate
P M Stuyt, P N Demacker, A Van't Laar
Page
of 18
Search research articles
Search
Showing results (11-20 of 171) with videos related to
Sort By:
Page
of 18
European Journal of Clinical Pharmacology
|
January 1, 1992
Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects
H A Kleinveld, P N Demacker, A F Stalenhoef
Clinical Chemistry
|
August 1, 1982
Enzymic and chemical-extraction determinations of free fatty acids in serum compared
P N Demacker, A G Hijmans, A P Jansen
British Medical Journal (Clinical Research Ed.)
|
September 20, 1986
Pancreatitis induced by oestrogen in a patient with type I hyperlipoproteinaemia
P M Stuyt, P N Demacker, A F Stalenhoef
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1986
A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia
P M Stuyt, P N Demacker, A van't Laar
Clinical Chemistry
|
June 1, 1984
Suitability of various control sera for use in testing the accuracy of cholesterol determination with enzymic kits
P N Demacker, G J Boerma, A P Jansen
Journal of Internal Medicine
|
December 1, 1991
N-acetylcysteine and serum concentrations of lipoprotein(a)
A A Kroon, P N Demacker, A F Stalenhoef
American Journal of Epidemiology
|
July 1, 1990
Effect of decaffeinated versus regular coffee on serum lipoproteins. A 12-week double-blind trial
M van Dusseldorp, M B Katan, P N Demacker
The Biochemical Journal
|
December 15, 1990
Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol
P N Demacker, M J Mol, A F Stalenhoef
Lancet (London, England)
|
March 20, 1993
Cyclosporin and serum lipids in renal transplant recipients
L B Hilbrands, P N Demacker, A J Hoitsma
Atherosclerosis
|
November 1, 1981
Long-term treatment of type III hyperlipoproteinemia with clofibrate
P M Stuyt, P N Demacker, A Van't Laar
Page
of 18